BioNews Texas | NIH Study For Secondary-Progressive MS Underway On Experimental Drug ... BioNews Texas In this study, Rituximab be delivered intravenously and directly into the cerebrospinal fluid by lumbar puncture of about 80 people with secondary-progressive Multiple Sclerosis. The study is funded by the National Institute of Neurological Disorders ... |
